Neuronal networks originating in the hypothalamic arcuate nucleus (Arc) play a fundamental role in controlling energy balance. In the Arc, neuropeptide Y (NPY)-producing neurons stimulate food intake, whereas neurons releasing the proopiomelanocortin (POMC)-derived peptide ␣-melanocyte-stimulating hormone (␣-MSH) strongly decrease food intake. There is growing evidence to suggest that apelin and its receptor may play a role in the central control of food intake, and both are concentrated in the Arc. We investigated the presence of apelin and its receptor in Arc NPY-and POMC-containing neurons and the effects of apelin on ␣-MSH release in the hypothalamus. We showed, by immunofluorescence and confocal microscopy, that apelin-immunoreactive (IR) neuronal cell bodies were distributed throughout the rostrocaudal extent of the Arc and that apelin was strongly colocalized with POMC, but weakly colocalized with NPY. However, there were numerous NPY-IR nerve fibers close to the apelin-IR neuronal cell bodies. By combining in situ hybridization with immunohistochemistry, we demonstrated the presence of apelin receptor mRNA in Arc POMC neurons. Moreover, using a perifusion technique for hypothalamic explants, we demonstrated that apelin-17 (K17F) increased ␣-MSH release, suggesting that apelin released somato-dendritically or axonally from POMC neurons may stimulate ␣-MSH release in an autocrine manner. Consistent with these data, hypothalamic apelin levels were found to be higher in obese db/db mice and fa/fa Zucker rats than in wild-type animals. These findings support the hypothesis that central apelin is involved in regulating body weight and feeding behavior through the direct stimulation of ␣-MSH release.
THE ARCUATE NUCLEUS (Arc) in the hypothalamus plays a key role in regulating food intake and energy homeostasis (62) . This structure contains two distinct groups of first-order neurons: a population-synthesizing proopiomelanocortin (POMC)-derived ␣-melanocyte-stimulating hormone (␣-MSH) and the cocaine-and amphetamine-regulated transcript (CART), and a second population-synthesizing neuropeptide Y (NPY) and Agouti gene-related peptide (AgRP) (62) . Arc POMC-immunoreactive (IR) neurons are activated in response to positive energy balance, whereas the NPY/AgRP-IR system is activated in response to negative energy balance, such as caloric restriction or starvation (6) . The NPY system stimulates food intake and decreases energy expenditure, whereas the activation of POMC neurons, via ␣-MSH release, has the opposite effect (44, 68) . NPY exerts its orexigenic effect by stimulating Y1 and Y5 receptors (43, 46) , whereas the anorectic activity of ␣-MSH is mediated by the activation of melanocortin receptor (MCR) subtypes 3 and 4 (62) . The Arc also responds to circulating leptin (26, 72) . Leptin suppresses the synthesis and release of NPY and AgRP and increases the synthesis and release of ␣-MSH and CART (64) . Missense mutations of the leptin receptor gene cause early-onset obesity associated with hyperleptinemia and hyperinsulinemia in obese fa/fa Zucker rats and in db/db mice (10, 14, 55) .
Apelin is a 36-amino acid peptide that was initially isolated from bovine stomach extracts (67) . It was identified as the endogenous ligand of the human orphan G protein-coupled receptor APJ (52, 67) . The apelin receptor gene has also been cloned in mouse and rat (20, 22, 36, 51) . Apelin is derived from a 77-amino acid precursor, preproapelin, for which cDNAs have been cloned from humans, cattle, rats, and mice (33, 67) . The COOH-terminal sequence of the apelin precursor is fully conserved in mammals, from Trp-55 to Phe-77, including the last 17 COOH-terminal amino acids (Lys-Phe-Arg-Arg-GlnArg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe, K17F). We have previously reported that the predominant molecular forms of endogenous apelin in rat brain and human plasma are the pyroglutamyl form of apelin-13 (pE13F) and K17F (2, 21) . Apelin is present in the heart, lung, stomach, adipose tissue, and vessels but is also found at high concentration in the brain (8, 36, 42, 57, 71) . Apelin-IR neuronal cell bodies are particularly abundant in the hypothalamic nuclei involved in feeding behavior, including the paraventricular nucleus (PVN), the dorsomedial (DMH) and ventromedial (VMH) nuclei, and the Arc (57) ; the highest density of apelin-IR cell bodies is found in the Arc. Apelin receptor mRNA is also widely distributed throughout the rat central nervous system (20, 42, 51) and is particularly abundant in the apelin-rich hypothalamic nuclei, including the supraoptic nucleus (SON), the PVN, and the Arc. Furthermore, apelin and apelin receptor mRNA colocalize with vasopressin in magnocellular secretory neurons (21, 50, 56, 59) , and apelin, like AVP, has been shown to participate in the maintenance of body fluid homeostasis in humans and rodents (2, 21) .
The role of apelin and its receptor in the central control of food intake remains a matter of debate. Intracerebroventricular (icv) apelin-12 injection has been shown to inhibit nocturnal food intake in rats (53) . Similarly, Sunter et al. (65) reported that icv apelin-13 reduced food intake in both fasted and fed rats. More recently, Clarke et al. (17) showed that the icv administration of apelin-13 decreased food and water intake in diet-induced obese (DIO) rats on the control diet. However, another study reported that the icv infusion of apelin-13 for 10 days significantly increased food intake on days 3-7 of infusion in C57BL/6 mice (69), whereas Taheri et al. (66) found that the icv injection of apelin-13 had no significant effect on food intake. These observations suggest that apelin may play a role in the central control of food intake. Arc POMC/NPY neurons are among the principal regulators of feeding behavior. We therefore hypothesized that apelin might regulate the POMC/NPY system. In this study, we first investigated the rostrocaudal distribution of apelin-IR perikarya within the Arc in colchicine-treated adult rats. We then investigated whether apelin and its receptor colocalized with POMC or NPY in Arc neurons. As apelin and its receptor were found to be coexpressed within POMC neurons, we then evaluated the effect of apelin on hypothalamic ␣-MSH release. Finally, as POMC neurons are targets of leptin and are also involved in regulating body weight, we investigated whether hypothalamic apelin levels were affected in two experimental animal models of obesity, db/db mice and Zucker rats.
MATERIALS AND METHODS

Drugs
K17F and the apelin fragment R10F (Arg-Leu-Ser-His-Lys-GlyPro-Met-Pro-Phe, R10F) were synthesized by NeoMPS (Strasbourg, France).
Antibodies
Rabbit polyclonal antibodies directed against the apelin fragment K17F (Lys-Phe-Arg-Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-ProMet-Pro-Phe, K17F) were produced and characterized in the laboratory, as previously described (21, 56) .
The polyclonal sheep antibody against NPY (AB-1583) was purchased from Chemicon International (Euromedex, Souffelweyersheim, France). The immunogen corresponds to a synthetic NPY peptide conjugated to bovine thyroglobulin. This antibody is well characterized (31) . The polyclonal goat antibody against ACTH/CLIP (E15, sc-18262) was obtained from Santa Cruz Biotechnology (Le Perray en Yvelines, France). This antibody is an affinity-purified goat antibody raised against a peptide mapping to an internal region of mouse POMC.
Apelin Antibody Characterization
The cross-reactivity of the apelin antiserum with various NH 2-and COOH-terminally truncated fragments of K17F and several other bioactive peptides has been previously investigated. Taking reactivity with pE13F as 100%, the reactivity of this antiserum with the various fragments can be ranked as follows K17F
The specificity of immunostaining for apelin was also checked on coronal Arc sections (Fig. 1) . Negative controls were performed by replacing the primary antibody with preimmune serum or 1% NGS in phosphate buffer (PB), and no staining was observed (Fig. 1, D and  E) . The specificity of the apelin antiserum was checked by incubating the diluted primary antiserum overnight with the immunizing peptide (K17F, 25 g/ml) before the experiment. The specificity of the apelin antibody was confirmed by the lack of staining observed following this prior incubation of the diluted primary antiserum with K17F (Fig. 1F) .
We carried out control experiments for each combination of primary and secondary antibodies to evaluate nonspecific secondary antibody binding and cross-reactivity between primary and secondary antibodies. In the absence of primary antibody for POMC (Fig. 1C) ) Zucker rats were used for morphological and biochemical experiments. Wistar rats, (280 -320 g), were used for ␣-MSH release studies. Rats were housed individually and maintained in controlled temperature and light conditions, under a 12:12-h light-dark cycle, with a normal standard diet (Usine Alimentation Rationnelle, Epinaysur-Orge, France) and water supplied ad libitum. The C57BL6/J mice were fed a chow diet from weaning until the age of 8 wk and were then either maintained on a normal chow diet (control group) or fed a high-fat diet (HFD) containing 20% protein, 35% carbohydrate, and 45% fat for 20 wk (Research Diet NJ). HFD mice were followed at regular intervals by measuring body weight and blood parameters (glucose, insulin) until the mice became obese and insulin resistant. HFD, age-matched control, and db/db mice (fed a chow diet) were killed at the age of 24 -33 wk. All experimental procedures were conducted in accordance with the guidelines for the care and use of experimental animals approved by the French National Institute of Medical Research (INSERM).
Tissue preparation for immunohistochemistry: icv injection of colchicine in anesthetized rats
Rats were anesthetized by intraperitoneal (ip) injection of Nembutal and placed in a stereotaxic apparatus (Kopf Instruments, Tujunga, CA) for the icv injection of 100 g of colchicine, as previously described (57) . The next day, the rats were anesthetized with Nembutal and transcardially perfused with 50 ml of 0.9% NaCl followed by 350 ml of 4% paraformaldehyde (PFA) in 0.1 M PB, pH 7.4. Brains were removed, post-fixed by incubation in 4% PFA overnight at 4°C, and cryoprotected by incubation overnight at 4°C with 20% sucrose in 0.1 M PB. Brains were frozen in liquid isopentane (Ϫ60°C). The entire Arc was cut into coronal sections (40 m) on a Leica microtome (Leica Instruments, Heidelberger, Germany) at Ϫ15°C.
Simultaneous Detection of Apelin and POMC or Apelin and NPY by Double Immunofluorescence Staining
Free-floating brain sections were permeabilized by incubation with 0.5% Triton X-100 in PB for 45 min and incubated with 3% H 2O2 in PB for 15 min. Sections were incubated in a blocking solution consisting of 10% normal horse serum (Sigma-Aldrich) in PB for 20 min. They were then incubated either with goat anti-ACTH/CLIP (1:500) or with sheep anti-NPY (1:500) antibody for 24 h at 4°C. Sections were then incubated for 1 h with an Alexa 488-labeled donkey anti-goat secondary antibody (1:500, Invitrogen) or with an Alexa 488-labeled donkey anti-sheep secondary antibody (1:500, Invitrogen). Sections were incubated with 3% normal goat serum for 1 h and then with a rabbit polyclonal antibody against K17F (1:500) for 48 h at 4°C. Apelin immunoreactivity was then detected by incubation with an Alexa 555-labeled goat anti-rabbit secondary antibody (1:500, Invitrogen) for 1 h. Sections were then washed, mounted in Aquamount, and covered with a coverslip.
Rostrocaudal distribution of apelin-IR cell bodies.
Using the rat brain atlas of Paxinos and Watson (54) as an anatomical guide, we divided the Arc into five (A to E) areas of equal length in the rostrocaudal plane, and each region was analyzed separately. Area A began rostrally at the retrochiasmatic area, the location of the first POMC-labeled cells, and area E corresponded to the end of the arcuate nucleus and/or the disappearance of POMC-labeled neurons. This rostrocaudal subdivision of the Arc has been used by several authors (15, 16, 48) .
Quantification of double-labeled apelin-POMC and apelin-NPY cells in the Arc. Arc sections from Sprague-Dawley (n ϭ 6), lean Zucker (n ϭ 5), and obese fa/fa Zucker (n ϭ 6) rats were analyzed. We quantified the colocalization of apelin-IR with POMC-or NPY-IR by acquiring confocal microscopy images (Leica Microsystems, Heidelberg, Germany) from the Arc at four rostrocaudal levels corresponding to panels A-D of 
Double Labeling for Apelin Receptor mRNA and POMC by a Combination of In Situ Hybridization and Immunohistochemistry
Tissue preparation. Sprague-Dawley rats (n ϭ 3) were fixed as described above. Their brains were embedded in paraffin by a standard procedure and then cut into 7-m-thick coronal sections, which were collected on silane-treated slides (SuperFrost, Menzel).
Synthesis of rat apelin receptor cRNA probes and in situ hybridization. Apelin receptor antisense and sense cRNA probes were synthesized by in vitro transcription as previously described (20, 58) . Sections were hybridized with the apelin receptor antisense and sense cRNA probes as previously described (20, 63) . Briefly, each slide was treated with proteinase K (20 g/ml, 10 min) and by acetylation and then incubated overnight in 80 l of hybridization mixture, containing 10.6 ϫ 10 5 cpm of the sense or antisense probe, in a humid chamber, at 50°C.
Immunohistochemistry for POMC after in situ hybridization. Immediately after in situ hybridization, sections were incubated with 3% H2O2 for 15 min, and then with 3% normal horse serum for 20 min. They were then incubated with a goat anti-ACTH/CLIP antibody (1:500) in 1% normal horse serum for 45 min followed by biotinylated horse anti-goat antibody (1:500, Vector Laboratories) for 30 min and ABC (1:125) for 30 min. The color reaction was developed for 8 -10 min with DAB ϩ (Dako, Trappes, France). Sections were washed In these experiments, middle arcuate nucleus (Arc) sections were used to check the specificity of immunostaining for POMC (A) and apelin (B). Negative controls were performed by replacing the primary antibody with 1% NGS in PB (C and D) or preimmune serum (E), resulting in an absence of staining. Immunolabeling with polyclonal anti-apelin antibodies in the Arc was abolished by prior incubation of antiserum with the apelin peptide K17F (25 g/ml diluted antiserum; F). Note the complete absence of immunostaining. Scale bar, 100 m.
overnight in 0.05 M Tris·HCl buffer, pH 7.6, dehydrated, dipped in Kodak NTB2 liquid emulsion, and placed against X-ray film for 10 wk. They were then counterstained with toluidine blue.
Quantitative analysis of apelin receptor mRNA colocalization with POMC-IR in the Arc. We quantified the POMC-IR neurons that also express apelin receptor mRNA, by analysis of the same rostrocaudal levels studied for the colocalization of apelin-IR with POMC-IR, on 12 different sections per animal. The total number of POMC-IR neurons and the number of POMC-IR neurons that also expressed apelin receptor mRNA were determined for the total Arc structure at ϫ400 magnification with a Leica DM 4000B microscope (Leica Microsystems, Heidelberg, Germany). Results are given as means Ϯ SE (of 12 values per total Arc per animal), and the percentage of POMC-IR neurons that also expressed the apelin receptor mRNA was calculated.
Preparation of hypothalamic extracts for apelin RIA. Adult male (C57BL6/J, normal diet, n ϭ 16; HFD, n ϭ 24; db/db, n ϭ 18) mice and lean (n ϭ 4) and obese fa/fa Zucker (n ϭ 4) rats were decapitated. The hypothalamus was homogenized in 10 -30 volumes of 0.4 N HClO 4 supplemented with 0.05% bovine serum albumin (BSA), as previously described (21) . The homogenate was centrifuged (17,000 g, 4°C, 20 min). The supernatant was collected, the pH was adjusted to 7 with 3 N KOH, and the mixture was left to stand for 15 min and then centrifuged (17,000 g, 4°C, 20 min). The supernatant was mixed with 1 ml of H 2O supplemented with 0.05% BSA and loaded onto a Sep-Pak C 18 cartridge (Waters, Milford, MA) preequilibrated with 2 ml of 100% ethanol, and washed with 5 ml of 0.1% BSA in H 2O. Apelin peptides were eluted with 1.5 ml of 100% ethanol. The peptides were dried and redissolved in 320 l of RIA buffer (19 mM NaH 2PO4 . H2O, 81 mM Na2HPO4 . 2H2O, 50 mM NaCl, 0.1% Triton X-100, 0.01% NaN 3, and 0.1% BSA) and subjected to radioimmunoassay (RIA; 100 l) as previously described (21) .
Apelin RIA procedure. Samples were mixed with 125 I-labeled pE13F (iodinated on Lys 8 by the Bolton and Hunter method, 2,200 Ci/mmol, Perkin-Elmer, Waltham, MA; 17,000 dpm) and polyclonal K17F antiserum (dilution: 1/7,500) to give a total volume of 0.2 ml and were incubated at 4°C overnight. We then added 0.3 ml of Amerlex (Amersham RPN 510), vortexed the tube, and incubated it at room temperature for 10 min. The tubes were centrifuged (2,600 g, 4°C, 20 min). The supernatants were removed, and the radioactivity contained in the precipitates was measured.
Static incubation of ventral hypothalamic explants. Rats (n ϭ 9 per group) were killed by decapitation, and the ventral hypothalamus, delineated by the posterior border of the optic chiasma, the anterior border of the mammillary bodies, and the fornix, was rapidly removed and transferred to an individual tube containing 1 ml of artificial cerebrospinal fluid medium (aCSF) composed of 26 mM NaHCO 3, 125 mM NaCl, 1.2 mM NaH 2PO4, 3 mM KCl, 2 mM CaCl2, 1.2 mM MgSO 4, 10 mM glucose, 1.8 g/l ascorbic acid, and 100 g/ml aprotinin (pH 7.4). The tubes were maintained at 37°C under an atmosphere containing 95% O 2-5% CO2 with continual shaking. After incubation for 1 h, the medium was renewed, and the explant was allowed to equilibrate for 45 min (basal release). The medium was then collected and radioimmunoassayed for ␣-MSH-like immunoreactivity (LI) (basal release). The hypothalamic explants were resuspended in fresh aCSF and incubated in the presence of K17F (10 Ϫ6 M) or R10F (10 Ϫ6 M) for 45 min. The medium was collected, stored at Ϫ20°C, and radioimmunoassayed. The viability of each hypothalamic explant was assessed by exposure to 56 mM KCl for 30 min.
␣-MSH RIA procedure. Synthetic rat ␣-MSH (1 g) was radiolabeled with 0.5 mCi Na 125 I (PerkinElmer, Waltham, MA) by the chloramine T method. Incubation was carried out in 0.1 M PB (pH 7.4) supplemented with 0.1% BSA and 0.1% Triton X-100. The final dilution of the antiserum against ␣-MSH (no. 812801) was 1:30,000, and the total amount of tracer was 8,000 cpm/tube. The production and characterization of antibodies against ␣-MSH (generously provided by Dr. M. C. Tonon, University of Rouen, France) has been described elsewhere (70) . Incubation was carried out at 4°C for 48 h. The antibody-bound fraction was separated by adding 100 l of bovine ␥-globulins (1%) and 1 ml of polyethylene glycol 8000 (20%). The tubes were maintained for 20 min at room temperature (21°C) and centrifuged (4,000 g, 4°C, 30 min). The supernatants were removed, and the precipitates containing the bound fraction were counted in a ␥-counter (LKB Wallac, Rockville, MD). Standard curves were established with synthetic rat ␣-MSH at concentrations of 2 to 5,000 pg/tube. The sensitivity threshold of the ␣-MSH RIA was 5 pg/tube. 
Image Acquisition
Arc sections were examined with a Leica TCS SP2 confocal laser scanning microscope (Leica Microsystems), equipped with an argon ion laser adjusted to 488 nm for Alexa 488 and a helium neon laser adjusted to 568 nm for Alexa 555. Sections were scanned, and double-labeled images were obtained with two photomultipliers and appropriate filter settings for the separate detection of fluorescence from Alexa 488 and Alexa 555. For in situ experiments, bright-field and dark-field images were acquired with a Leica DM 4000B microscope (Leica Microsystems) and Leica Application Suite software.
Data Analysis
Statistical analyses were performed with PRISM (GraphPad, San Diego, CA) or StatView (S.A.S. Institute, Cary, NC). All data are expressed as means Ϯ SE, and results were analyzed by one-way or two-way ANOVA with or without subsequent Fisher's post hoc least squares difference correction for multiple comparisons or unpaired Student's t-tests. For significant results, when appropriate, the F-test was followed by a Dunnett's multiple comparison post hoc test. Differences were considered significant if a P value below 0.05 was obtained.
RESULTS
Rostrocaudal Distribution of Apelin-IR Cell Bodies in the Arc
The rostrocaudal distribution of apelin-IR perikarya in the Arc was investigated in Sprague-Dawley and lean and obese fa/fa Zucker rats. The administration of colchicine (100 g icv) induced strong apelin immunoreactivity in neuronal cell bodies throughout the Arc. The distribution of apelin in the Arc of Sprague-Dawley rats is represented in schematic diagrams (Fig. 2) . Five rostrocaudal areas of the Arc were examined. Apelin-IR perikarya were found from the retrochiasmatic area to the mammillary recess. Apelin-IR cell bodies were found principally in the ventrolateral and dorsolateral subdivisions of the Arc (Fig. 2) . A similar rostrocaudal distribution of apelin-IR cell bodies was observed in lean and obese fa/fa Zucker rats (not shown).
Distribution of Apelin-and POMC-IR Cell Bodies in the Arc
The presence of multipolar apelin-IR cell bodies in the lateral part of the Arc, which is known to contain the major population of POMC neurons, led us to investigate the possible presence of apelin in the POMC neurons of control SpragueDawley and lean and obese fa/fa Zucker rats. Dual immunofluorescence experiments combined with confocal microscopy revealed a high degree of colocalization of the two markers in neuronal cell bodies at the three rostrocaudal levels of the Arc in Sprague-Dawley (Fig. 3) and lean (Fig. 4) and obese fa/fa (Fig. 5 ) Zucker rats.
Quantification of double-stained Arc sections revealed that 41 Ϯ 6, 37 Ϯ 3, and 45 Ϯ 3% of POMC-IR cells displayed apelin immunoreactivity in Sprague-Dawley and lean and obese fa/fa Zucker rats, respectively, with no significant difference between groups. POMC-IR was detected in 89 Ϯ 3, 88 Ϯ 2 and 90 Ϯ 2% of cells displaying apelin immunoreactivity in Sprague-Dawley and lean and obese fa/fa Zucker rats, respectively, with no significant difference between groups. Furthermore, single-plane confocal images of double-stained neurons revealed the presence of three pools of intracytoplasmic vesicles: vesicles containing apelin-IR (red), POMC-IR (green), or both (yellow) (Fig. 5J) . Apelin-IR nerve fibers (Fig. 5K , arrows) were seen near fibers containing POMC-IR (Fig. 5K , arrowheads) or fibers expressing both markers (Fig. 5K, asterisk) . These data confirm the specificity of immunolabeling and suggest that, despite their colocalization within the same cells, apelin and POMC may be at least partially segregated into different cytoplasmic compartments.
Distribution of Apelin and NPY-IR Cell Bodies and Fibers in the Arc
We investigated the possible presence of apelin within orexigenic NPY-IR neurons in the Arc by carrying out dualimmunofluorescence experiments in Sprague-Dawley and lean and obese fa/fa Zucker rats. The localization of NPY-IR cell bodies in the dorso-and ventromedial parts of the Arc (Fig. 6 , A-C, in green) contrasts with the ventro-and dorsolateral distribution of apelin-IR neurons (Fig. 6, A-C, in red) . We found that 5 Ϯ 1, 8 Ϯ 1, and 6 Ϯ 1% of NPY-IR cells contained apelin-IR in Sprague-Dawley and lean and obese fa/fa Zucker rats, respectively. The quantification of confocal images showed that apelin was colocalized with NPY-IR cells in 6 Ϯ 2, 9 Ϯ 2, and 11 Ϯ 2% of the apelin-IR cells in Sprague-Dawley and lean and obese fa/fa Zucker rats, respectively, with no significant difference between groups. Furthermore, high magnification dual-immunofluorescence experiments revealed a high density of NPY-IR nerve fibers close to apelin-IR neuronal cell bodies in obese fa/fa Zucker rats (Fig.  6D) . Furthermore, the intensity of NPY-IR in the perikarya and the density of nerve fibers appeared greater in the Arc of obese fa/fa Zucker rats (Fig. 6C ) than in that of lean Zucker rats (Fig.  6B) , as previously described (5, 6, 47) .
Apelin Receptor mRNA in Arc POMC-IR Neurons
We also investigated the expression of apelin receptor mRNA by Arc POMC neurons. We carried out double-labeling experiments combining immunohistochemistry and in situ hybridization (20, 58) . The sections containing the Arc hybridized with the apelin receptor antisense riboprobe, giving a clear, positive signal for many neuronal cells (Fig. 7, A and B) . By contrast, no hybridization signal was obtained with the sense riboprobe (Fig. 7C) . The quantification of double-labeled sections by bright-field microscopy indicated that 56 Ϯ 4% of the POMC-IR neurons (brown cells) expressed apelin receptor mRNA (detected of silver grains; Fig. 7 arrows) . However, 44 Ϯ 4% of the POMC-IR neurons did not express apelin receptor mRNA (Fig. 7B, arrowheads) , which was also detected in non POMC-IR cells of unknown phenotype.
Effects of K17F and R10F on ␣-MSH Release by Ventral Hypothalamic Explants
Apelin and apelin receptor mRNA colocalized with POMC in Arc POMC neurons. This led us to investigate the effect of apelin on ␣-MSH release. We carried out static incubations of rat ventral hypothalamic explants and assessed the effect of the active (K17F) and inactive (R10F) apelin fragments (25, 56) on ␣-MSH release in a highly sensitive RIA. The addition of K17F (10 Ϫ6 M) to the survival medium significantly increased (ϩ132%, P Ͻ 0.01) ␣-MSH release from the hypothalamic explants (Fig. 8) . By contrast, the administration of R10F (10 Ϫ6 M) had no effect on the amount of ␣-MSH released into the incubation medium (Fig. 8) .
Hypothalamic Apelin Levels in Mouse and Rat Experimental Models of Obesity
We further investigated the possible effects of pathological variations of body mass on hypothalamic apelin levels, by quantifying apelin levels throughout the hypothalamus of control lean and obese HFD (C57BL6/J) and homozygous (db/db) mice and lean and obese fa/fa Zucker rats, with a highly specific apelin RIA (21) . In C57BL6/J mice, the HFD resulted in hypothalamic apelin-IR levels 61% higher than those of normal chow diet-fed mice (6.6 Ϯ 0.7 vs. 4.1 Ϯ 0.2 fmol/mg tissue, P Ͻ 0.005; Fig. 9 ). Hypothalamic apelin-IR levels in obese db/db mice fed a normal chow diet were also 54% higher than those in normal C57BL6/J mice (6.3 Ϯ 0.3 vs. 4.1 Ϯ 0.2 fmol/mg tissue). A similar pattern of regulation (e.g., a significant 23% increase in hypothalamic apelin levels) was observed when obese fa/fa Zucker rats were compared with lean rats (9.8 Ϯ 0.9 vs. 8.0 Ϯ 0.4 fmol/mg tissue; Fig. 9 ).
DISCUSSION
The neuropeptide apelin acts on specific receptors expressed in rat hypothalamic nuclei involved in the control of body fluid homeostasis and neuroendocrine regulation (20, 42, 50) . High densities of apelin neurons have been observed in the rat hypothalamus, particularly in the SON, PVN, and Arc (56, 57) . We report here that apelin-IR neurons are distributed throughout the rostrocaudal extent of the rat Arc. Quantitative analysis demonstrated that 89% of apelin-IR neurons contained POMC, whereas fewer than 10% contained NPY. However, numerous NPY-IR nerve fibers were detected close to apelin-IR neuronal cell bodies. We also show that more than half the Arc POMC neurons expressed apelin receptor mRNA and that K17F strongly increased ␣-MSH release from rat hypothalamic explants, whereas the inactive apelin fragment R10F did not. This suggests that apelin may be somatodendritically or axonally released from POMC neurons, stimulating in an autocrine manner the release of ␣-MSH, a neuropeptide reducing food intake and inducing weight loss (28, 32) . Consistent with these data, we observed an increase in hypothalamic apelin levels in obese db/db mice and obese fa/fa Zucker rats and in HFD mice.
Such upregulation has already been reported for apelin levels in the adipose tissue and blood (8, 12, 19, 23, 35) .
Apelin-IR cell bodies were found from the retrochiasmatic area to the end of the Arc, concentrating principally in the ventrolateral and dorsolateral regions of the nucleus. This rostrocaudal distribution of apelin-IR overlapped the previously reported distribution of POMC-IR cell bodies (18) , suggesting that these two markers may be coexpressed. This hypothesis is supported by the presence of apelin-IR in brain nuclei known to contain POMC-IR neurons, such as the PVN, DMH, and VMH (9, 21, 56, 57) . Double-immunofluorescence labeling and quantitative analysis further demonstrated that apelin strongly colocalized with POMC in Arc neurons in control and lean and obese fa/fa Zucker rats. The colocalization of apelin and POMC and the reported anorexigenic activity of apelin (17, 53, 65) suggest a role for apelin in regulating the melanocortin system. We tested this hypothesis by evaluating the presence of apelin receptor mRNA in POMC neurons. By combining in situ hybridization with immunohistochemistry, we showed that 56% of the Arc POMC-IR neurons expressed apelin receptor mRNA. The product of POMC processing, ␣-MSH, is considered to be one of the predominant regulators of food intake. We therefore assessed the physiological relevance of this colocalization by investigating the effects of apelin on ␣-MSH release. K17F application onto rat hypothalamic explants strongly increased ␣-MSH release, whereas the inactive apelin fragment R10F had no such effect. This strongly suggests that apelin is released from POMC neurons and increases ␣-MSH release by a direct effect on autoreceptors expressed by POMC apelin-containing neurons. Arc POMC neurons also express MC3-R (38) , which contributes to the inhibitory effect of ␣-MSH on its own release. Thus, ␣-MSH neurons contain apelin, in addition to apelin receptors and MC3-R, suggesting direct autocrine feedback regulation of these neurons by the two neuropeptides.
Arc POMC neurons also express leptin (15) and NPY Y1 and Y5 receptors (29) . By acting on these receptors, leptin and NPY increase and decrease ␣-MSH release, respectively. Arc POMC neurons send projections to multiple, distant, secondorder nuclei involved in appetite regulation. These nuclei Fig. 8 . Effects of K17F and R10F on ␣-melanocyte-stimulating hormone (␣-MSH) release by hypothalamic explants. Test substances K17F (10 Ϫ6 M) and R10F (10 Ϫ6 M) were added to survival medium, and the amount of ␣-MSH secreted by the hypothalamic explants was determined by RIA. K17F provoked a marked increase in ␣-MSH levels in the incubation medium. By contrast, R10F had no significant effect on ␣-MSH release from hypothalamic explants. Values are means Ϯ SE; n ϭ 9 per group of animals. Basal ␣-MSH levels in survival medium were 92 Ϯ 37 pg/ml for the control group, 70 Ϯ 16 pg/ml for the group treated with K17F, and 63 Ϯ 14 pg/ml for the group treated with R10F. Data were analyzed by ANOVA followed by Dunnett's multiple comparison test **P Ͻ 0.01; ns, non significant vs. control group. Fig. 9 . Hypothalamic apelin levels in control and diabetic (db/db) mice and obese fa/fa Zucker rats. In C57BL6/J [normal diet (ND), n ϭ 16; high-fat diet (HFD), n ϭ 24] and db/db mice (n ϭ 18) and in lean and obese fa/fa Zucker rats (ND, n ϭ 4 per group), levels of hypothalamic apelin immunoreactivity were determined with a specific RIA, as previously described (21) . Data are expressed as means Ϯ SE of 3 separate experiments carried out in triplicate and analyzed with ANOVA followed by Fisher's post hoc least squares difference correction for multiple comparisons for mice and unpaired Student's t-tests for rats. *P Ͻ 0.05, ** P Ͻ 0.001 vs. corresponding group. include the PVN, which contains corticotropin-releasing factor (CRF) neurons expressing MC4-R (37, 49) . In the PVN, ␣-MSH increases CRF release via MC4-R in response to systemic signals concerning nutrient availability, imposing tonic inhibition on appetite and feeding behavior. Similarly, apelin has been shown to stimulate CRF release from hypothalamic explants in vitro (66) , probably via apelin receptors highly expressed in the PVN (20, 51) . This suggests that the apelin released by POMC neurons may, like ␣-MSH, be involved in the transsynaptic regulation of CRF neurons. These two peptides may therefore act in concert to inhibit food intake. The stimulation of CRF neurons by Arc POMC neurons is partially restrained by Arc NPY-and AgRP-containing neurons. Thus, when NPY/AgRP neurons are activated, they release the following into the PVN: 1) NPY, which inhibits CRF release via Y1 receptors expressed on PVN CRF neurons (34) and 2) AgRP, which blocks the binding of ␣-MSH to MC4-R, causing an increase in feeding behavior (60) . Thus apelin, by increasing the release of ␣-MSH and CRF, should decrease food intake in a similar manner to ␣-MSH.
Consistent with this hypothesis, Sunter et al. (65) showed that icv apelin-13 reduced food intake in fasted and fed rats. Similar results were reported by Clarke et al. (17) , who showed that apelin-13, given icv 15-30 min before the light was switched off, decreased food and water intake and respiratory exchange ratio in DIO rats on the control diet. Another study reported that the icv injection of apelin-12 decreased food intake when administered at the onset of the dark cycle (53) .
The ventrolateral and dorsolateral localization of apelin-IR neurons in the Arc contrasts with the distribution of NPY-IR neurons, which are mostly located in the ventromedial and dorsomedial parts of the nucleus (29) , consistent with our data showing a very low percentage of NPY-apelin-IR cells in the Arc of control and obese rats. Nevertheless, we showed that numerous NPY-IR nerve fibers and, probably, nerve terminals in control and obese fa/fa Zucker rats are close to POMC apelin-containing neurons, expressing Y1 and Y5 receptors (29) . NPY has been shown to inhibit the activity of POMC neurons by activating these receptors (62) , suggesting a similar neuromodulator role for NPY in Arc apelin/POMC neurons of nonobese and obese animals. Further investigation of this possible role is required. However, some neuronal cells devoid of POMC-IR contained apelin receptor mRNA, suggesting that apelin receptors in the Arc are not expressed solely by melanocortin neurons. We therefore cannot exclude the possibility that apelin regulates the release of other neuromediators/neuropeptides, such as AgRP, CART, dopamine, galanin, or GHRH, in the Arc in a paracrine manner, although it is unlikely to regulate NPY release, because Taheri et al. (66) reported no effect of apelin on NPY release from rat hypothalamic explants in vitro.
We then investigated whether pathological body weight variations affected hypothalamic apelin levels, using a highly specific and selective apelin RIA previously developed and validated in our laboratory (21) . One of the most striking findings was the significantly higher levels of apelin in the hypothalamus (including the PVN, DM, VMH, and Arc) of obese HFD mice and of obese/diabetic animals (db/db mice or obese fa/fa Zucker rats). The latter models of obesity/diabetes are characterized, in the Arc, by lower POMC mRNA levels and higher NPY mRNA levels (4, 6) and, in the PVN, by lower ␣-MSH levels and higher NPY levels (40, 41) . The decrease in POMC neuron activity and the increase in NPY neuron activity may be partly explained by the lack of leptin signaling in these animals. In the Arc, both NPY/AgRP and POMC/CART neurons express leptin receptors (3, 15) . In control animals, in the presence of leptin, Arc POMC neurons displayed increased signaling activity to second-order neurons, leading to an increase in satiety and a decrease in food intake, whereas NPY/ AgRP neurons displayed a decrease in activity, removing their inhibition on melanocortin neurons (61, 62) . By contrast, genetically obese animals secreted high levels of leptin (45) , but this molecule could not stimulate ␣-MSH release or inhibit NPY release due to the lack of activity of the mutated leptin receptor. Thus, leptin receptor-deficient obese animals behave as if they are in a constant state of deprivation. In this context, the increase in hypothalamic apelin levels observed in these animals may constitute an adaptive process, counteracting the lack of leptin signaling and the decrease in POMC neuron activity.
The opposite regulation of apelin and POMC levels is consistent with the detection of cytoplasmic vesicles immunoreactive for apelin, POMC, or both peptides in Arc POMC neurons. This suggests that the two markers may be differentially released from two different vesicular pools within the same cells. This hypothesis is also supported by the presence of apelin-positive/POMC-negative and POMC-positive/apelinnegative varicosities in nerve fibers. Additional double-immunogold electron microscopy experiments are required to confirm this hypothesis.
Recent studies have shown that apelin, which has recently been identified as an adipokine, plays a major role in obesityassociated complications (8, 12, 24, 71) . Apelin and its receptor have been detected in adipocytes (8, 23, 39) . HFDs significantly increase preproapelin mRNA levels in the subcutaneous adipose tissue and apelin levels in the plasma of db/db mice (8, 30) . We show here that C57/BL6 obese mice fed an HFD had higher hypothalamic apelin levels than animals fed a normal diet, which would normally be expected to result in an increase in ␣-MSH release. However, the beneficial effect of apelin on weight gain is counteracted by the downregulation of hypothalamic apelin receptors previously reported in DIO rats fed an HFD (17) . This downregulation may also account for the diminished metabolic responses to centrally administered apelin-13 observed in these animals. Furthermore, in humans, particularly those with morbid obesity with or without diabetes, a positive correlation among plasma apelin concentration, body mass index, and leptin levels has been reported (23, 35) . Plasma apelin levels have also been shown to decrease after 12 wk of diet-induced weight loss in obese women (13) . Our data show that both systemic and central apelin levels are upregulated in obese individuals. As apelin has been seen as a beneficial adipokine in obesity (1, 7) , the increase in hypothalamic apelin levels in obese animals may help to counteract the increase in body mass by increasing ␣-MSH release, this effect being progressively blunted by the desensitization of apelin receptors. Given the physiological roles of apelin in the cardiovascular system and in the control of glucose homeostasis, the overproduction of apelin in the hypothalamus of obese animals and in the adipose tissue and blood may, as suggested by others (11, 27) , provide a means of protection before the emergence of well-known obesity-related disorders such as type 2 diabetes or cardiovascular dysfunction.
In conclusion, the coexistence of apelin and its receptor with POMC in Arc neurons, the stimulatory autocrine effect of apelin on ␣-MSH release, and the central and peripheral upregulation of apelin in obese animals are likely to maintain body weight homeostasis. Our data provide strong support for a role for brain apelin and its receptor in the pathology of obesity-related disorders and suggest that apelin may be a common endogenous substrate for both obesity and hypertension.
